Myeloid cell–derived HOCl is a paracrine effector that trans-inhibits IKK/NF-κB in melanoma cells and limits early tumor progression

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works https://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License.

Author Information

Altmetric

Article usage

View Full Text

Science Signaling

Vol 14, Issue 677
06 April 2021

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Signaling.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Myeloid cell–derived HOCl is a paracrine effector that trans-inhibits IKK/NF-κB in melanoma cells and limits early tumor progression

Message Subject (Your Name) has forwarded a page to you from Science Signaling

Message Body (Your Name) thought you would like to see this page from the Science Signaling web site.

Your Personal Message

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Powerpoint
Print
Alerts

Please log in to add an alert for this article.

Log In with your AAAS ID

Sign In to Email Alerts with your Email Address
Email
Citation tools
Myeloid cell–derived HOCl is a paracrine effector that trans-inhibits IKK/NF-κB in melanoma cells and limits early tumor progression

By Tracy W. Liu, Seth T. Gammon, Ping Yang, David Fuentes, David Piwnica-Worms

Science Signaling06 Apr 2021

MPO in host myeloid cells has antitumor effects during the early stages of melanoma growth.

Supplementary Materials

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share
Myeloid cell–derived HOCl is a paracrine effector that trans-inhibits IKK/NF-κB in melanoma cells and limits early tumor progression

By Tracy W. Liu, Seth T. Gammon, Ping Yang, David Fuentes, David Piwnica-Worms

Science Signaling06 Apr 2021

MPO in host myeloid cells has antitumor effects during the early stages of melanoma growth.

Supplementary Materials
Share This Article: